3
Announcements
Trials
Browse
Landscape
Phase
Phase 4
1
Status
Unknown
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
CNS
1
Conditions
Brain Neoplasms
5
Melanoma
3
Stomach Neoplasms
2
Neoplasms
2
Glioma
2
Glioblastoma
2
Breast Neoplasms
2
Thyroid Diseases
1
Skin Neoplasms
1
Sarcoma
1
Pancreatic Neoplasms
1
Paget Disease, Extramammary
1
Ovarian Neoplasms
1
Neuroma, Acoustic
1
Lung Neoplasms
1
Laryngeal Neoplasms
1
Irritable Bowel Syndrome
1
Gastrointestinal Stromal Tumors
1
Gastrointestinal Diseases
1
Gastroesophageal Reflux
1
Fallopian Tube Neoplasms
1
Endometrial Neoplasms
1
Colorectal Neoplasms
1
Cholangiocarcinoma
1
Cerebrovascular Disorders
1
Carcinoma, Hepatocellular
1
Barrett Esophagus
1
Astrocytoma
1
Adenomatous Polyps
1
Adenolymphoma
1
Interventions
Vitamin E
1
Magnetic Resonance Imaging
1
Fluorescein
1
Enhanced Recovery After Surgery
1
Dexmedetomidine
1
Bupivacaine
1
Aspirin
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Interventional
×
Cerebrovascular Disorders
×
Fluorescein
×
Clear all
NCT02478346
2017-02-14
Fluoescein
AdventHealth
Phase 4
Unknown
200 enrolled